Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: Sulfasalazine in Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating sulfasalazine for metastatic colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Tanta University | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: RECRUITING